Stephen M. Robb
Analyst · Caris
Thanks, Larry, and hello, everyone. I'm going to review our fourth quarter and fiscal year results and discuss our outlook for fiscal '13. Starting with the fourth quarter. Sales grew 4%. We had gains in all 4 reportable segments. Excluding the impact of the Aplicare and HealthLink acquisitions, sales were up more than 2%, driven by the benefits of pricing and base volume growth. These benefits were partially offset by unfavorable foreign exchange rates and higher trade spending, both of which impacted sales by nearly 1 point. As expected, our fourth quarter gross margin decreased 80 basis points to 42.7% versus 43.5% in the year ago quarter. While pricing and cost savings more than offset higher commodity costs, increased costs for compensation, manufacturing and logistics had a material impact on margin. Mix also had a negative impact on margin of about 80 basis points, but less than we saw in the third quarter, when we had particularly strong merchandising events. Turning to selling and administrative expense. The rate of spending came in pretty much as we expected at about 14% of sales. The year-over-year increase reflected higher compensation expenses and our investments in IT systems and new R&D facilities. Net of all these factors, we delivered earnings from continuing operations of $174 million or $1.32 of diluted earnings per share. This compares with $169 million or $1.26 in the year-ago quarter, an increase of 5% diluted EPS. Next, I'll turn to our results for the full fiscal year. Sales were up a strong 5% for the fiscal year, with gains in all 4 segments. This reflects improving U.S. categories, strong results on our base business, a very successful pricing execution and the benefits of the recent acquisitions. Excluding the impact of acquisitions, sales grew a healthy 4%. Fiscal '12 gross margin decreased 140 basis points to 42.1% compared with 43.5% in fiscal '11. As we discussed before, the biggest factors were higher commodity costs and inflation in manufacturing and logistics, partially offset by pricing, as well as another year of very strong cost savings exceeding $100 million. Turning to selling and administrative expense. The rate of spending came in at about 15% of sales, as expected. This is about 1 point higher than we've historically seen, primarily due to our investments in IT systems and new R&D facilities. Our tax rate for the fiscal year was about 31%. This is lower than our typical range of 34% to 35%, due primarily to lower tax on foreign earnings. For fiscal '13, we continue to expect an effective tax rate of approximately 34%. Net of all of these factors, we delivered earnings from continuing operations of $543 million or $4.10 diluted earnings per share. This is a 4% increase in diluted EPS versus last year, excluding the fiscal '11 noncash goodwill impairment charge on Burt's Bees. Free cash flow from continuing operations in fiscal '12 was $428 million or about 8% of sales versus $462 million or about 9% in fiscal '11. The decrease was driven mainly by lower tax payments in fiscal '11, resulting from favorable tax depreciation rules and the timing of tax payments in fiscal '12. We continue to expect free cash flow to improve in fiscal '13 and beyond as we rebuild our margins and complete our infrastructure investments. As a reminder, we define free cash flow as cash provided by operations less capital expenditures. We ended the year with a debt-to-EBITDA ratio of 2.5:1, at the upper end of our targeted range of 2 to 2.5. We anticipate further reducing our leverage in fiscal '13 to about the midpoint of our targeted range. Next, I'll turn to our outlook for fiscal '13, which does reflect some updated assumptions. We continue to anticipate sales growth in the range of 2% to 4% behind moderate category improvement and strong innovation. Since our last update in May, foreign currencies are slightly more negative, and planned pricing is being reduced in light of the current softening commodity environment. We anticipate the majority of our fiscal '13 pricing being International to help offset foreign exchange and higher inflationary costs. Net of these factors, we are still comfortable with our outlook for sales growth in the range of 2% to 4%. We now expect EBIT margin to be up 25 to 50 basis points for the full fiscal year, reflecting recent softness in commodity prices, partially offset by more moderate pricing assumptions and decreasing foreign currencies. Our assumptions for higher global manufacturing and logistics costs, strong cost savings and reduced impact from mix remain unchanged. International was the one area that we continue to closely monitor both from a sales and margin standpoint. Although we are executing well in most markets, 2 of our larger businesses are in Latin America: Argentina and Venezuela. Both of which have some form of price controls in place and challenging economic environments. Turning to selling and administrative expense. We continue to anticipate expenses for systems and facilities investments, as well as other infrastructure-related investments to be in the range of $50 million to $55 million or about equal to fiscal '12. Both the SAP implementation in Latin America and the move to a new innovation center in Pleasanton are on track and expected to be completed by the end of fiscal '13. Finally, as noted in today's press release, we are continuing with plans to optimize our real estate portfolio, including selling our former R&D facility in Pleasanton, California. Although we continue to anticipate a net gain on real estate transactions, it is no longer expected in fiscal '13, and we are still refining the timing and other assumptions. For this reason, our updated outlook no longer includes a one-time gain of $0.05 to $0.07 diluted earnings per share. Net of all these factors, we continue to anticipate fiscal '13 diluted earnings per share from continuing operations in the range of $4.20 to $4.35 per share. And looking closer in, we expect sales in the first half of fiscal '13 to be generally in the range of our full year outlook of 2% to 4%. We anticipate gross margin to begin improving in the first half. But EBIT margin will decline in the first half for 2 reasons: first, we're still completing our remaining IT and facilities investments; second, we continue to expect inflationary pressures, and worsening currencies have also become a concern. EBIT margin is expected to grow in the back half of the fiscal year, supporting the full year increase of 25 to 50 basis points. We also continue to anticipate free cash flow of about 9% of sales in fiscal '13. Our priorities for the use of cash remain unchanged. These include investing in organic and inorganic growth, supporting the dividend, maintaining our targeted debt leverage ratio and returning any remaining excess cash to shareholders. For fiscal '13, we project capital spending in the range of $230 million to $240 million, which includes the investments in systems and facilities. We continue to expect capital spending to decline after fiscal '13 to roughly $200 million to $210 million per year. In closing, I'm very pleased with our results in the fourth quarter and the fiscal year. And looking ahead, we are confident about our plans for fiscal '13 and beyond. With that, I'll turn it over to Don to recap, and we will open it up for questions.